New York City, NY -- (SBWIRE) -- 10/23/2013 -- StockMarketIntel.com issues a special report on the following stocks: Federal Home Loan Mortgage Corp (OTCBB:FMCC), Advanced Micro Devices, Inc. (NYSE:AMD), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Cereplast Inc (OTCMKTS:CERP)
Federal Home Loan Mortgage Corp (OTCBB:FMCC) gained 9.68%, trading on 18.59 million shares, to end the trade at $1.70. The stock changed hands in a range of $1.55 to $1.70, bringing its market capitalization to about $1.11billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.24 and was moved to the maximum level of $5.00. Federal Home Loan Mortgage Corporation (Freddie Mac) conducts business in the United States residential mortgage market and the global securities market. The Company operates in three segments: Single-family Guarantee, Investments, and Multifamily. The Single-family Guarantee segment reflects results from the Company's single-family credit guarantee activities. The Investments segment reflects results from the Company's investment, funding and hedging activities.
What was the Moving Force behind FMCC on Bullish Run? Read This Research Report
Advanced Micro Devices, Inc. (NYSE:AMD) declined -5.64%, to complete the trading session at $3.18, with a total volume of 92.51 million shares. The stock, on average, trades on a volume of 33.76 million shares. It floated in a range of $3.12 to $3.34 during the last trading session, with a beta value of 2.28. Its market capitalization now moved to about $2.29 billion. In the past 52 weeks, the share price has not declined below $1.81 and above $4.65. Advanced Micro Devices, Inc. (AMD) is a global semiconductor company with facilities around the world. The Company offers x86 microprocessors, as standalone devices or as incorporated as an accelerated processing unit (APU), for the commercial and consumer markets, embedded microprocessors for commercial, commercial client and consumer markets and chipsets for desktop and mobile devices, including mobile personal computers, or PCs, and tablets, professional workstations and servers and graphics, video and multimedia products for desktop and mobile devices, including mobile PCs and tablets, home media PCs and professional workstations, servers and technology for game consoles.
Will AMD Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) recorded a gain of 10.88% and was in a range of $3.00-$3.27 before closing at $3.26. The stock completed the day with a total volume of 14.11 million shares, versus an average volume of 13.94 million shares. The share price hit its 52-week low of $2.62 and $24.59 was the best price. ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. ARIAD’s first medicine, Iclusig, is approved in the United States for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia that is resistant or intolerant to prior TKI therapy. As of January 11, 2013, additional clinical trials of Iclusig in other cancers were ongoing.
Is it the Right to Grab ARIA after the Recent Slump? Get Free Trend Analysis Here
Cereplast Inc (OTCMKTS:CERP) declined -4.14% yesterday, bringing its market capitalization around $10.01 million. The share price, after opening at $0.01, made a high of $0.01 and hovered above $0.01 to end the day at $0.0139. The total number of shares that changed hands during the session was 13.62 million shares, as compared to average trading volume of 10.84 million shares. Cereplast, Inc. (Cereplast) is engaged in developing and commercializing bio-based resins through two product families: Cereplast Compostables Resins, which are compostable, renewable, ecologically sound substitutes for petroleum-based plastics, and Cereplast Sustainables resins (including the Cereplast Hybrid Resins product line), which replaces up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources.
Will CERP Reach the Bottom after Yesterday’s Correction? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)